{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "import ast"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# JSON_FILE = \"sample-studies.json\"\n",
    "JSON_FILE = \"../../data/clinicaltrialsgov/ctg-studies.json\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_data_into_df():\n",
    "    # Load JSON data\n",
    "    with open(JSON_FILE, \"r\") as file:\n",
    "        data = json.load(file)\n",
    "\n",
    "    # Convert JSON to DataFrame\n",
    "    df = pd.json_normalize(data)\n",
    "\n",
    "    return data, df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "json_data, df = load_data_into_df()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# specific to observational studies\n",
    "obsCol = [ \n",
    " 'protocolSection.designModule.patientRegistry', \n",
    " 'protocolSection.designModule.designInfo.observationalModel', \n",
    " 'protocolSection.designModule.designInfo.timePerspective', \n",
    " 'protocolSection.eligibilityModule.studyPopulation', \n",
    " 'protocolSection.eligibilityModule.samplingMethod', \n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "requiredColumns = [\n",
    "    # id\n",
    "    'protocolSection.identificationModule.nctId',\n",
    "    'protocolSection.identificationModule.officialTitle',\n",
    "    'protocolSection.identificationModule.acronym',\n",
    "\n",
    "    # intro\n",
    "    'protocolSection.descriptionModule.briefSummary',\n",
    "    'protocolSection.descriptionModule.detailedDescription',\n",
    "    'protocolSection.conditionsModule.conditions',\n",
    "    'protocolSection.conditionsModule.keywords',\n",
    "\n",
    "    # study design\n",
    "    'protocolSection.designModule.studyType',\n",
    "    'protocolSection.designModule.phases',\n",
    "    'protocolSection.designModule.designInfo.allocation',\n",
    "    'protocolSection.designModule.designInfo.interventionModel',\n",
    "    'protocolSection.designModule.designInfo.primaryPurpose',\n",
    "    'protocolSection.designModule.designInfo.maskingInfo.masking',\n",
    "    'protocolSection.designModule.enrollmentInfo.count',\n",
    "    'protocolSection.designModule.enrollmentInfo.type',\n",
    "\n",
    "    # arms and their interventions\n",
    "    'protocolSection.armsInterventionsModule.armGroups',\n",
    "    'protocolSection.armsInterventionsModule.interventions',\n",
    "\n",
    "    # outcomes designed to be tracked\n",
    "    'protocolSection.outcomesModule.primaryOutcomes',\n",
    "    'protocolSection.outcomesModule.secondaryOutcomes',\n",
    "\n",
    "    # eligibility\n",
    "    'protocolSection.eligibilityModule.eligibilityCriteria',\n",
    "    'protocolSection.eligibilityModule.healthyVolunteers',\n",
    "    'protocolSection.eligibilityModule.sex',\n",
    "    'protocolSection.eligibilityModule.minimumAge',\n",
    "    'protocolSection.eligibilityModule.stdAges',\n",
    "\n",
    "    # location\n",
    "    'protocolSection.contactsLocationsModule.overallOfficials',\n",
    "    'protocolSection.contactsLocationsModule.locations',\n",
    "\n",
    "    # pubmed references\n",
    "    'protocolSection.referencesModule.references',\n",
    "    'protocolSection.referencesModule.seeAlsoLinks',\n",
    "\n",
    "    # regulation on drug\n",
    "    'protocolSection.oversightModule.isFdaRegulatedDrug', \n",
    "    'protocolSection.oversightModule.isFdaRegulatedDevice',\n",
    "\n",
    "    # participant cohorts\n",
    "    'resultsSection.participantFlowModule.preAssignmentDetails',\n",
    "    'resultsSection.participantFlowModule.recruitmentDetails',\n",
    "    'resultsSection.participantFlowModule.groups',\n",
    "    'resultsSection.participantFlowModule.periods',\n",
    "\n",
    "    # baseline/demographic characteristics - eg. race, age, sex of patients in different groups\n",
    "    'resultsSection.baselineCharacteristicsModule.groups',\n",
    "    'resultsSection.baselineCharacteristicsModule.denoms',\n",
    "    'resultsSection.baselineCharacteristicsModule.measures',\n",
    "    'resultsSection.baselineCharacteristicsModule.populationDescription',\n",
    "\n",
    "    # actual outcomes\n",
    "    'resultsSection.outcomeMeasuresModule.outcomeMeasures',\n",
    "\n",
    "    # causing deaths, serious effect or non-serious effect\n",
    "    'resultsSection.adverseEventsModule.frequencyThreshold',\n",
    "    'resultsSection.adverseEventsModule.timeFrame',\n",
    "    'resultsSection.adverseEventsModule.description',\n",
    "    'resultsSection.adverseEventsModule.eventGroups',\n",
    "    'resultsSection.adverseEventsModule.seriousEvents',\n",
    "    'resultsSection.adverseEventsModule.otherEvents', \n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "csv_df = df[requiredColumns]\n",
    "csv_df.to_csv(\"../../data/clinicaltrialsgov/CLL_343_SelectedFields.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>protocolSection.identificationModule.nctId</th>\n",
       "      <th>protocolSection.identificationModule.officialTitle</th>\n",
       "      <th>protocolSection.identificationModule.acronym</th>\n",
       "      <th>protocolSection.descriptionModule.briefSummary</th>\n",
       "      <th>protocolSection.descriptionModule.detailedDescription</th>\n",
       "      <th>protocolSection.conditionsModule.conditions</th>\n",
       "      <th>protocolSection.conditionsModule.keywords</th>\n",
       "      <th>protocolSection.designModule.studyType</th>\n",
       "      <th>protocolSection.designModule.phases</th>\n",
       "      <th>protocolSection.designModule.designInfo.allocation</th>\n",
       "      <th>...</th>\n",
       "      <th>resultsSection.baselineCharacteristicsModule.denoms</th>\n",
       "      <th>resultsSection.baselineCharacteristicsModule.measures</th>\n",
       "      <th>resultsSection.baselineCharacteristicsModule.populationDescription</th>\n",
       "      <th>resultsSection.outcomeMeasuresModule.outcomeMeasures</th>\n",
       "      <th>resultsSection.adverseEventsModule.frequencyThreshold</th>\n",
       "      <th>resultsSection.adverseEventsModule.timeFrame</th>\n",
       "      <th>resultsSection.adverseEventsModule.description</th>\n",
       "      <th>resultsSection.adverseEventsModule.eventGroups</th>\n",
       "      <th>resultsSection.adverseEventsModule.seriousEvents</th>\n",
       "      <th>resultsSection.adverseEventsModule.otherEvents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01520922</td>\n",
       "      <td>A Phase II, Multi-centre Study Investigating t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This is a Phase II, open label, single arm, mu...</td>\n",
       "      <td>This is a Phase II, open label, single arm, mu...</td>\n",
       "      <td>[Chronic Lymphocytic Leukemia (CLL), Leukaemia...</td>\n",
       "      <td>[Relapsed or Refractory Chronic Lymphocytic Le...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>NA</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'units': 'Participants', 'counts': [{'groupI...</td>\n",
       "      <td>[{'title': 'Age, Continuous', 'paramType': 'ME...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Number of Parti...</td>\n",
       "      <td>5</td>\n",
       "      <td>From the first dose of study medication to 60 ...</td>\n",
       "      <td>Serious adverse events (SAEs) and and non-seri...</td>\n",
       "      <td>[{'id': 'EG000', 'title': 'Ofatumumab + Bendam...</td>\n",
       "      <td>[{'term': 'Anaemia', 'organSystem': 'Blood and...</td>\n",
       "      <td>[{'term': 'Anaemia', 'organSystem': 'Blood and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00802737</td>\n",
       "      <td>A Single-arm, International, Multi-center Tria...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of the trial is to investigate the...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Leukaemia, Lymphocytic, Chronic]</td>\n",
       "      <td>[Maintenance, Retreatment, Chronic lymphocytic...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE4]</td>\n",
       "      <td>NA</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'units': 'Participants', 'counts': [{'groupI...</td>\n",
       "      <td>[{'title': 'Age, Continuous', 'paramType': 'ME...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Number of Parti...</td>\n",
       "      <td>5</td>\n",
       "      <td>On-treatment serious adverse events (SAEs) and...</td>\n",
       "      <td>SAEs and non-serious AEs were reported for mem...</td>\n",
       "      <td>[{'id': 'EG000', 'title': '2000 mg Ofatumumab ...</td>\n",
       "      <td>[{'term': 'Bronchopneumonia', 'organSystem': '...</td>\n",
       "      <td>[{'term': 'Diarrhea', 'organSystem': 'Gastroin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00410163</td>\n",
       "      <td>An Open-labeled, Randomized, Two-dose, Paralle...</td>\n",
       "      <td>BIFROST</td>\n",
       "      <td>To investigate the safety and efficacy of two ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Leukaemia, Lymphocytic, Chronic]</td>\n",
       "      <td>[B-cell, cyclophosphamide, fludarabine, Chroni...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'units': 'Participants', 'counts': [{'groupI...</td>\n",
       "      <td>[{'title': 'Age, Continuous', 'paramType': 'ME...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Number of Parti...</td>\n",
       "      <td>5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>During the Extended Follow-up Phase, from 2 ye...</td>\n",
       "      <td>[{'id': 'EG000', 'title': 'Ofatumumab 500 mg +...</td>\n",
       "      <td>[{'term': 'Neutropenia', 'organSystem': 'Blood...</td>\n",
       "      <td>[{'term': 'Neutropenia', 'organSystem': 'Blood...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00349349</td>\n",
       "      <td>A Single-arm, International, Multi-center Tria...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Leukaemia, Lymphocytic, Chronic]</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'units': 'Participants', 'counts': [{'groupI...</td>\n",
       "      <td>[{'title': 'Age, Continuous', 'paramType': 'ME...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Number of Parti...</td>\n",
       "      <td>5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[{'id': 'EG000', 'title': '2000 mg Ofatumumab ...</td>\n",
       "      <td>[{'term': 'Pneumonia', 'organSystem': 'Infecti...</td>\n",
       "      <td>[{'term': 'Fatigue', 'organSystem': 'General d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01178086</td>\n",
       "      <td>Rituximab in the Treatment of Chronic Lymphocy...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This observational study will assess the thera...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[Lymphocytic Leukemia, Chronic]</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'units': 'Participants', 'counts': [{'groupI...</td>\n",
       "      <td>[{'title': 'Age, Continuous', 'paramType': 'ME...</td>\n",
       "      <td>Baseline characteristics of EAS has been repor...</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Progression-Fre...</td>\n",
       "      <td>5</td>\n",
       "      <td>Baseline up to 24 months</td>\n",
       "      <td>Analysis was performed on safety analysis set.</td>\n",
       "      <td>[{'id': 'EG000', 'title': 'Unselected Populati...</td>\n",
       "      <td>[{'term': 'Anemia', 'organSystem': 'Blood and ...</td>\n",
       "      <td>[{'term': 'Anemia', 'organSystem': 'Blood and ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 45 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "  protocolSection.identificationModule.nctId  \\\n",
       "0                                NCT01520922   \n",
       "1                                NCT00802737   \n",
       "2                                NCT00410163   \n",
       "3                                NCT00349349   \n",
       "4                                NCT01178086   \n",
       "\n",
       "  protocolSection.identificationModule.officialTitle  \\\n",
       "0  A Phase II, Multi-centre Study Investigating t...   \n",
       "1  A Single-arm, International, Multi-center Tria...   \n",
       "2  An Open-labeled, Randomized, Two-dose, Paralle...   \n",
       "3  A Single-arm, International, Multi-center Tria...   \n",
       "4  Rituximab in the Treatment of Chronic Lymphocy...   \n",
       "\n",
       "  protocolSection.identificationModule.acronym  \\\n",
       "0                                          NaN   \n",
       "1                                          NaN   \n",
       "2                                      BIFROST   \n",
       "3                                          NaN   \n",
       "4                                          NaN   \n",
       "\n",
       "      protocolSection.descriptionModule.briefSummary  \\\n",
       "0  This is a Phase II, open label, single arm, mu...   \n",
       "1  The purpose of the trial is to investigate the...   \n",
       "2  To investigate the safety and efficacy of two ...   \n",
       "3  The purpose of this study is to determine whet...   \n",
       "4  This observational study will assess the thera...   \n",
       "\n",
       "  protocolSection.descriptionModule.detailedDescription  \\\n",
       "0  This is a Phase II, open label, single arm, mu...      \n",
       "1                                                NaN      \n",
       "2                                                NaN      \n",
       "3                                                NaN      \n",
       "4                                                NaN      \n",
       "\n",
       "         protocolSection.conditionsModule.conditions  \\\n",
       "0  [Chronic Lymphocytic Leukemia (CLL), Leukaemia...   \n",
       "1                  [Leukaemia, Lymphocytic, Chronic]   \n",
       "2                  [Leukaemia, Lymphocytic, Chronic]   \n",
       "3                  [Leukaemia, Lymphocytic, Chronic]   \n",
       "4                    [Lymphocytic Leukemia, Chronic]   \n",
       "\n",
       "           protocolSection.conditionsModule.keywords  \\\n",
       "0  [Relapsed or Refractory Chronic Lymphocytic Le...   \n",
       "1  [Maintenance, Retreatment, Chronic lymphocytic...   \n",
       "2  [B-cell, cyclophosphamide, fludarabine, Chroni...   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "  protocolSection.designModule.studyType protocolSection.designModule.phases  \\\n",
       "0                         INTERVENTIONAL                            [PHASE2]   \n",
       "1                         INTERVENTIONAL                            [PHASE4]   \n",
       "2                         INTERVENTIONAL                            [PHASE2]   \n",
       "3                         INTERVENTIONAL                            [PHASE2]   \n",
       "4                          OBSERVATIONAL                                 NaN   \n",
       "\n",
       "  protocolSection.designModule.designInfo.allocation  ...  \\\n",
       "0                                                 NA  ...   \n",
       "1                                                 NA  ...   \n",
       "2                                         RANDOMIZED  ...   \n",
       "3                                     NON_RANDOMIZED  ...   \n",
       "4                                                NaN  ...   \n",
       "\n",
       "  resultsSection.baselineCharacteristicsModule.denoms  \\\n",
       "0  [{'units': 'Participants', 'counts': [{'groupI...    \n",
       "1  [{'units': 'Participants', 'counts': [{'groupI...    \n",
       "2  [{'units': 'Participants', 'counts': [{'groupI...    \n",
       "3  [{'units': 'Participants', 'counts': [{'groupI...    \n",
       "4  [{'units': 'Participants', 'counts': [{'groupI...    \n",
       "\n",
       "  resultsSection.baselineCharacteristicsModule.measures  \\\n",
       "0  [{'title': 'Age, Continuous', 'paramType': 'ME...      \n",
       "1  [{'title': 'Age, Continuous', 'paramType': 'ME...      \n",
       "2  [{'title': 'Age, Continuous', 'paramType': 'ME...      \n",
       "3  [{'title': 'Age, Continuous', 'paramType': 'ME...      \n",
       "4  [{'title': 'Age, Continuous', 'paramType': 'ME...      \n",
       "\n",
       "  resultsSection.baselineCharacteristicsModule.populationDescription  \\\n",
       "0                                                NaN                   \n",
       "1                                                NaN                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4  Baseline characteristics of EAS has been repor...                   \n",
       "\n",
       "   resultsSection.outcomeMeasuresModule.outcomeMeasures  \\\n",
       "0  [{'type': 'PRIMARY', 'title': 'Number of Parti...      \n",
       "1  [{'type': 'PRIMARY', 'title': 'Number of Parti...      \n",
       "2  [{'type': 'PRIMARY', 'title': 'Number of Parti...      \n",
       "3  [{'type': 'PRIMARY', 'title': 'Number of Parti...      \n",
       "4  [{'type': 'PRIMARY', 'title': 'Progression-Fre...      \n",
       "\n",
       "  resultsSection.adverseEventsModule.frequencyThreshold  \\\n",
       "0                                                  5      \n",
       "1                                                  5      \n",
       "2                                                  5      \n",
       "3                                                  5      \n",
       "4                                                  5      \n",
       "\n",
       "        resultsSection.adverseEventsModule.timeFrame  \\\n",
       "0  From the first dose of study medication to 60 ...   \n",
       "1  On-treatment serious adverse events (SAEs) and...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                           Baseline up to 24 months   \n",
       "\n",
       "      resultsSection.adverseEventsModule.description  \\\n",
       "0  Serious adverse events (SAEs) and and non-seri...   \n",
       "1  SAEs and non-serious AEs were reported for mem...   \n",
       "2  During the Extended Follow-up Phase, from 2 ye...   \n",
       "3                                                NaN   \n",
       "4     Analysis was performed on safety analysis set.   \n",
       "\n",
       "      resultsSection.adverseEventsModule.eventGroups  \\\n",
       "0  [{'id': 'EG000', 'title': 'Ofatumumab + Bendam...   \n",
       "1  [{'id': 'EG000', 'title': '2000 mg Ofatumumab ...   \n",
       "2  [{'id': 'EG000', 'title': 'Ofatumumab 500 mg +...   \n",
       "3  [{'id': 'EG000', 'title': '2000 mg Ofatumumab ...   \n",
       "4  [{'id': 'EG000', 'title': 'Unselected Populati...   \n",
       "\n",
       "    resultsSection.adverseEventsModule.seriousEvents  \\\n",
       "0  [{'term': 'Anaemia', 'organSystem': 'Blood and...   \n",
       "1  [{'term': 'Bronchopneumonia', 'organSystem': '...   \n",
       "2  [{'term': 'Neutropenia', 'organSystem': 'Blood...   \n",
       "3  [{'term': 'Pneumonia', 'organSystem': 'Infecti...   \n",
       "4  [{'term': 'Anemia', 'organSystem': 'Blood and ...   \n",
       "\n",
       "      resultsSection.adverseEventsModule.otherEvents  \n",
       "0  [{'term': 'Anaemia', 'organSystem': 'Blood and...  \n",
       "1  [{'term': 'Diarrhea', 'organSystem': 'Gastroin...  \n",
       "2  [{'term': 'Neutropenia', 'organSystem': 'Blood...  \n",
       "3  [{'term': 'Fatigue', 'organSystem': 'General d...  \n",
       "4  [{'term': 'Anemia', 'organSystem': 'Blood and ...  \n",
       "\n",
       "[5 rows x 45 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_df.head()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "msc-thesis-BHB9aft-",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
